Skip to content
Home/Companies/MedTech/Axion Biosystems

Axion Biosystems

MedTech·United States·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Axion Biosystems?

Axion Biosystems is an American MedTech company, currently owned by Summa Equity since 2021.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Summa Equity
Investor
Summa Equity
Summa Equity Fund II · 2019 · Buyout

Key facts

HQUnited States
SectorMedTech
StatusActive

More from Summa Equity Fund II

Other portfolio companies in the same fund.

G-CON Manufacturing
Exited 2025
HealthcareUS· 2021
to Bridgepoint
Holdbart
Active
ConsumerNorway· 2021
myneva
myneva
Active
SaaSGermany· 2021
Nofitech
Active
IndustrialsNorway· 2021
Sengenics
Active
BiotechSingapore· 2020
Infobric
Infobric
Exited 2025
SoftwareSweden· 2019
to KKR

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Axion Biosystems?

Axion Biosystems is currently owned by Summa Equity, through Summa Equity Fund II, since 2021.

When did Summa Equity acquire Axion Biosystems?

Summa Equity acquired Axion Biosystems in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue